MAPT and Alzheimer disease: Sometimes it is difficult to correctly diagnose these diseases, but cerebrospinal fluid (CSF)-based diagnosis of AD using the biomarkers amyloid β42 (Aβ42), total tau protein (t-tau), and hyperphosphorylated tau (p-tau) has been reported as useful [15].